PT  - JOURNAL ARTICLE
AU  - Subramaniam, R.M.
AU  - Truong, M.
AU  - Peller, P.
AU  - Sakai, O.
AU  - Mercier, G.
TI  - Fluorodeoxyglucose–Positron-Emission Tomography Imaging of Head and Neck Squamous Cell Cancer
AID  - 10.3174/ajnr.A1760
DP  - 2010 Apr 01
TA  - American Journal of Neuroradiology
PG  - 598--604
VI  - 31
IP  - 4
4099  - http://www.ajnr.org/content/31/4/598.short
4100  - http://www.ajnr.org/content/31/4/598.full
SO  - Am. J. Neuroradiol.2010 Apr 01; 31
AB  - SUMMARY: The hybrid technique of PET/CT has significantly impacted the imaging and management of HNSCC since its introduction in 2001 and has become the technique of choice for imaging of this cancer. Diagnostic FDG-PET/CT is useful for identification of an unknown primary tumor, delineation of extent of primary tumor, detection of regional lymph node involvement even in a normal-sized node, detection of distant metastases and occasional synchronous primary tumor, assessment of therapy response, and long-term surveillance for recurrence and metastases. The role of PET/CT is evolving in radiation therapy planning. Combined diagnostic PET/CT provides the best anatomic and metabolic in vivo information for the comprehensive management of HNSCC. CRcomplete responseDCTcontrast enhanced diagnostic CT18Ffluorine-18FDGfluorodeoxyglucoseFDG-PETfluorodeoxyglucose–positron-emission tomographyFNAfine-needle aspirationGTVgross tumor volumeHNSCChead and neck squamous cell carcinomasIMRTintensity modulated radiation therapyMmetastasisNnodePETpositron-emission tomographyPTVplanning target volumeRDresidual diseaseSCCsquamous cell carcinomaSUVstandard uptake valueSUVmaxmaximum SUVTtumor